<p>Join Meritxell Alberich Jordà, an EHA Board member and a principal investigator from Prague, as she shares her journey to becoming a recognised research scientist in hematology, and the role EHA has played along the way. Her lab studies hematopoietic and leukemic stem cells, focusing on how disruptions in transcriptional regulation and inflammatory signalling drive the development and persistence of acute myeloid leukemia. </p><p> </p><p>Meri reflects on how her early research interests evolved over time, how key career decisions shaped the questions she pursues today, and what she finds most rewarding about leading a lab. Tune in to hear what she wishes she’d known at the very beginning of her journey. </p><p><br></p><p>Guest: Associate Prof Meritxell Alberich Jordà</p><p>Institute of Molecular Genetics of the Czech Academy of Sciences, Laboratory of Haematooncology Head, Prague, Czech Republic The Childhood Leukaemia Investigation Prague in the Department of Pediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic </p><p><br></p><p>Host: Isabel Olivera Martinez, PhD</p><p><br></p><p><strong>Learn More</strong></p><p><br></p><p>What did you think of this podcast? Share your opinions with us in this short feedback survey.</p><p><a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠Provide Feedback⁠⁠⁠</a></p><p><br></p><p>Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.</p><p><a href="https://ehacampus.ehaweb.org/" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠https://ehaedu.org/Campus⁠⁠⁠</a></p><p><br></p><p>Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.</p><p>Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠https://www.instagram.com/EHA_Hematology/⁠⁠⁠</a></p><p>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠https://e-h-a.link/facebook⁠⁠⁠</a></p><p>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠https://www.linkedin.com/company/eha/⁠⁠⁠</a></p><p>Email us: [email protected]</p><p>Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠https://eha.news/subscribe⁠⁠⁠</a> </p><p><br></p><p><br></p>